Symposium on allergic lung disease. V. Selective drug treatments for bronchial asthma.
This paper presents a brief summary of the evidence for selective beta-stimulant and selective glucocorticoid treatments of bronchial asthma. If they are used together correctly, and with sodium cromoglycate in suitable cases, the physician will achieve better control of bronchial asthma in most patients.
D000287:Administration, Topical; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D005938:Glucocorticoids / Q000627:therapeutic use; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects; D006801:Humans; D009921:Metaproterenol / Q000627:therapeutic use*; D008901:Mineralocorticoids / Q000627:therapeutic use; D009132:Muscles / Q000187:drug effects; D010636:Phenols / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects; D014132:Trachea
D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D008901:Mineralocorticoids; D010636:Phenols; D009921:Metaproterenol